Immediate Impact
59 standout
Citing Papers
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
2024 Standout
Targeting KRAS in cancer
2024 Standout
Works of Deepankar Sinha being referenced
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Deepankar Sinha | 58 | 45 | 10 | 87 | 62 | 27 | 346 | |
| Michael Wiedemann | 6 | 19 | 1 | 14 | 63 | 24 | 339 | |
| Mahdi Moqri | 5 | 11 | 2 | 12 | 25 | 20 | 324 | |
| Hee Byung Koh | 8 | 28 | 1 | 2 | 55 | 31 | 394 | |
| Suchitra Kumari | 2 | 9 | 5 | 10 | 31 | 333 | ||
| George Hodge | 65 | 113 | 4 | 5 | 28 | 393 | ||
| Minho Cho | 10 | 19 | 2 | 5 | 20 | 34 | 372 | |
| Hiroshi Osada | 5 | 79 | 3 | 28 | 24 | 41 | 367 | |
| Yating Li | 3 | 19 | 2 | 36 | 29 | 378 | ||
| Japneet Kaur | 1 | 17 | 7 | 9 | 9 | 24 | 300 | |
| Baomin Chen | 2 | 11 | 5 | 37 | 25 | 380 |
All Works
Login with ORCID to disown or claim papers
Loading papers...